Switch to: References

Add citations

You must login to add citations.
  1. Avoidance of nocebo effects by coincident naming of treatment benefits during the medical interview for informed consent—Evidence from dynamometry.Nina Zech, Matthias Schrödinger & Ernil Hansen - 2022 - Frontiers in Psychology 13.
    IntroductionIn the context of giving risk information for obtaining informed consent, it is not easy to comply with the ethical principle of “primum nihil nocere.” Carelessness, ignorance of nocebo effects and a misunderstood striving for legal certainty can lead doctors to comprehensive and brutal risk information. It is known that talking about risks and side effects can even trigger those and result in distress and nonadherence to medication or therapy.MethodsRecently, we have reported on significant clinically relevant effects of verbal and (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Informed Consent in Asymmetrical Relationships: an Investigation into Relational Factors that Influence Room for Reflection.Shannon Lydia Spruit, Ibo Poel & Neelke Doorn - 2016 - NanoEthics 10 (2):123-138.
    In recent years, informed consent has been suggested as a way to deal with risks posed by engineered nanomaterials. We argue that while we can learn from experiences with informed consent in treatment and research contexts, we should be aware that informed consent traditionally pertains to certain features of the relationships between doctors and patients and researchers and research participants, rather than those between producers and consumers and employers and employees, which are more prominent in the case of engineered nanomaterials. (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Informed Consent in Asymmetrical Relationships: an Investigation into Relational Factors that Influence Room for Reflection.Shannon Lydia Spruit, Ibo van de Poel & Neelke Doorn - 2016 - NanoEthics 10 (2):123-138.
    In recent years, informed consent has been suggested as a way to deal with risks posed by engineered nanomaterials. We argue that while we can learn from experiences with informed consent in treatment and research contexts, we should be aware that informed consent traditionally pertains to certain features of the relationships between doctors and patients and researchers and research participants, rather than those between producers and consumers and employers and employees, which are more prominent in the case of engineered nanomaterials. (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • When Respecting Autonomy Is Harmful: A Clinically Useful Approach to the Nocebo Effect.Daniel Londyn Menkes, Jason Adam Wasserman & John T. Fortunato - 2017 - American Journal of Bioethics 17 (6):36-42.
    Nocebo effects occur when an adverse effect on the patient arises from the patient's own negative expectations. In accordance with informed consent, providers often disclose information that results in unintended adverse outcomes for the patient. While this may adhere to the principle of autonomy, it violates the doctrine of “primum non nocere,” given that side-effect disclosure may cause those side effects. In this article we build off previous work, particularly by Wells and Kaptchuk and by Cohen :3–11.[Taylor & Francis Online], (...)
    Download  
     
    Export citation  
     
    Bookmark   20 citations